Literature DB >> 12391213

Selective delivery of augmented IL-2 receptor signals to responding CD8+ T cells increases the size of the acute antiviral response and of the resulting memory T cell pool.

Laurence E Cheng1, Philip D Greenberg.   

Abstract

CD8(+) T cells respond to IL-2 produced both endogenously and by CD4(+) Th during an antiviral response. However, IL-2R signals can potentially promote CD8(+) T cell death as well as proliferation, making it unclear whether IL-2R signals provide a predominantly positive or negative effect upon CD8(+) T cell responses to viral infection. To more precisely define the direct role of IL-2R signaling on CD8(+) T cells during the response to a virus, we examined the effect of delivering augmented IL-2R signals selectively to CD8(+) T cells responding to lymphocytic choriomeningitis virus infection. Although naive CD8(+) T cells are competent to produce IL-2, CD8(+) T cells lose this capacity upon differentiation into effector CD8(+) T cells. However, effector CD8(+) T cells do retain the capacity to produce GM-CSF upon Ag stimulation. Thus, to deliver enhanced autocrine IL-2R signals to CD8(+) T cells, we established a transgenic mouse strain expressing a chimeric GM-CSF/IL-2R (GMIL2R). As GM-CSF production is Ag dependent, the GMIL2R delivers an augmented IL-2R signal exclusively to CD8(+) T cells responding to Ag. Following lymphocytic choriomeningitis virus infection, GMIL2R transgenic mice exhibited an increase in both the peak CD8(+) T cell response achieved and the size of the resulting memory pool established. Upon secondary viral challenge, the GMIL2R also enhanced the proliferative response of memory CD8(+) T cells. Thus, our findings indicate that IL-2 delivery to responding CD8(+) T cells is a limiting factor in both the acute and memory antiviral responses.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12391213     DOI: 10.4049/jimmunol.169.9.4990

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Abrogating Cbl-b in effector CD8(+) T cells improves the efficacy of adoptive therapy of leukemia in mice.

Authors:  Ingunn M Stromnes; Joseph N Blattman; Xiaoxia Tan; Sara Jeevanjee; Hua Gu; Philip D Greenberg
Journal:  J Clin Invest       Date:  2010-09-20       Impact factor: 14.808

2.  Peripheral CD8+ T cell tolerance to self-proteins is regulated proximally at the T cell receptor.

Authors:  Ryan M Teague; Philip D Greenberg; Carla Fowler; Maria Z Huang; Xiaoxia Tan; Junko Morimoto; Michelle L Dossett; Eric S Huseby; Claes Ohlén
Journal:  Immunity       Date:  2008-05       Impact factor: 31.745

3.  Co-expression of tumor antigen and interleukin-2 from an adenoviral vector augments the efficiency of therapeutic tumor vaccination.

Authors:  Benjamin Anderschou Holbech Jensen; Maria Abildgaard Steffensen; Karen Nørgaard Nielsen; Jan Pravsgaard Christensen; Allan Randrup Thomsen; Peter Johannes Holst
Journal:  Mol Ther       Date:  2014-07-15       Impact factor: 11.454

4.  CD4+CD25+ regulatory T cells control CD8+ T-cell effector differentiation by modulating IL-2 homeostasis.

Authors:  Alice McNally; Geoffrey R Hill; Tim Sparwasser; Ranjeny Thomas; Raymond J Steptoe
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-18       Impact factor: 11.205

5.  Eomesodermin Increases Survival and IL-2 Responsiveness of Tumor-specific CD8+ T Cells in an Adoptive Transfer Model of Cancer Immunotherapy.

Authors:  Aki Furusawa; John Reiser; Kavitha Sadashivaiah; Haley Simpson; Arnob Banerjee
Journal:  J Immunother       Date:  2018 Feb/Mar       Impact factor: 4.456

Review 6.  Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies.

Authors:  Kristin G Anderson; Ingunn M Stromnes; Philip D Greenberg
Journal:  Cancer Cell       Date:  2017-03-13       Impact factor: 31.743

7.  Transient enhanced IL-2R signaling early during priming rapidly amplifies development of functional CD8+ T effector-memory cells.

Authors:  Iris Castro; Michael J Dee; Thomas R Malek
Journal:  J Immunol       Date:  2012-09-26       Impact factor: 5.422

8.  4-1BB Signaling Enhances Primary and Secondary Population Expansion of CD8+ T Cells by Maximizing Autocrine IL-2/IL-2 Receptor Signaling.

Authors:  Ho S Oh; Beom K Choi; Young H Kim; Don G Lee; Sunhee Hwang; Myoung J Lee; Sang H Park; Yong-Soo Bae; Byoung S Kwon
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

9.  Immunogenic, but not steady-state, antigen presentation permits regulatory T-cells to control CD8+ T-cell effector differentiation by IL-2 modulation.

Authors:  Alice McNally; Michael McNally; Ryan Galea; Ranjeny Thomas; Raymond J Steptoe
Journal:  PLoS One       Date:  2014-01-13       Impact factor: 3.240

Review 10.  Regulation of Effector and Memory CD8 T Cell Differentiation by IL-2-A Balancing Act.

Authors:  Vandana Kalia; Surojit Sarkar
Journal:  Front Immunol       Date:  2018-12-20       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.